Tower Research Capital LLC (Trc) Titan Pharmaceuticals Inc Transaction History

Tower Research Capital LLC (Trc)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.26 - $0.48 $7 - $13	-29 Reduced 1.84%	1,544 $0
Q2 2023 Aug 14, 2023	SELL	$0.65 - $0.82 $25 - $31	-39 Reduced 2.42%	1,573 $1,000
Q4 2022 Feb 10, 2023	BUY	$0.77 - $22.8 $1,241 - $36,753	1,612 New	1,612 $1,000
Q2 2022 Aug 15, 2022	SELL	$0.38 - $0.94 $3,815 - $9,438	-10,041 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$0.89 - $1.26 $8,843 - $12,519	9,936 Added 9462.86%	10,041 $10,000
Q4 2021 Feb 14, 2022	SELL	$1.02 - $1.93 $1,049 - $1,985	-1,029 Reduced 90.74%	105 $0
Q3 2021 Nov 15, 2021	BUY	$1.87 - $2.57 $1,821 - $2,503	974 Added 608.75%	1,134 $2,000
Q2 2021 Aug 16, 2021	SELL	$2.24 - $2.9 $14,920 - $19,316	-6,661 Reduced 97.65%	160 $0
Q1 2021 May 17, 2021	SELL	$2.66 - $4.23 $3,061 - $4,868	-1,151 Reduced 14.44%	6,821 $20,000
Q4 2020 Feb 16, 2021	BUY	$3.0 - $6.0 $23,916 - $47,832	7,972 New	7,972 $26,000

Ticker TTNP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,629,200
Market Cap $49.4M
Description
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the Euro...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.